scholarly journals Safety, feasibility, and comfort of hepatic angiography and transarterial intervention with radial access for hepatocellular carcinoma

JGH Open ◽  
2021 ◽  
Author(s):  
Hidenori Toyoda ◽  
Satoshi Yasuda ◽  
Shohei Shiota ◽  
Shohei Chatani ◽  
Ryota Tsukii ◽  
...  
2015 ◽  
Vol 8 (1) ◽  
pp. 94-100 ◽  
Author(s):  
Akihiro Okano ◽  
Masaya Ohana

Spontaneous regression of hepatocellular carcinoma (HCC) is a rare phenomenon. We followed a detailed clinical course of a spontaneous and complete disappearance of HCC during a short interval. A 73-year-old man with hepatitis B virus infection presented with a 15-mm mass in the right anterior superior segment of the liver. The mass was diagnosed as HCC by imaging findings. We found an elevated serum α-fetoprotein (AFP) level of 748 ng/ml. The tumor regressed to 6 mm on imaging examination, and the AFP serum level decreased to 87.8 ng/ml 1 month after the diagnostic hepatic angiography. Therefore, the patient was followed up without any treatment for HCC. The tumor disappeared 5 months later when the AFP serum level was 5.0 ng/ml. The diagnostic hepatic angiography might have had some effect on the spontaneous regression of HCC in the present case.


Kanzo ◽  
1990 ◽  
Vol 31 (7) ◽  
pp. 784-789
Author(s):  
Yuuichi TANABE ◽  
Sachiko SHINOMIYA ◽  
Kouhei TOMINAGA ◽  
Kaichiro HIROSHIGE ◽  
Nobuhiro KOYANAGI ◽  
...  

2011 ◽  
Vol 79 (1) ◽  
pp. e5-e9
Author(s):  
Yasushi Itou ◽  
Shigenori Nagata ◽  
Yasuhiko Tomita ◽  
Katsuyuki Nakanishi

1989 ◽  
Vol 22 (3) ◽  
pp. 791-797
Author(s):  
Yasutaka HIRAIDE ◽  
Kuniaki KOJIMA ◽  
Kohhi SAI ◽  
Yasuhiko NISHIMURA ◽  
Kohichi OKUYAMA ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Hiroaki Takahashi ◽  
Kensaku Mori ◽  
Yuta Sekino ◽  
Toshiyuki Okumura ◽  
Takashi Hiyama ◽  
...  

Given the growing interest in using proton beam therapy (PBT) for hepatocellular carcinoma (HCC), it is possible that transarterial chemoembolization (TACE) could be used for selected patients who have previously undergone PBT. However, these cases can be technically challenging to treat and require appropriate preparation. Thus, we aimed to identify angiographic findings in this setting. We retrospectively identified 31 patients (28 men and 3 women, mean age: 69 years, range: 43–84 years) who underwent hepatic angiography plus TACE or transarterial infusion chemotherapy (TAI) for HCC that recurred after PBT (July 2007 to June 2018). We discovered four angiographic findings, which we speculate were related to the previous PBT. 18 patients experienced recurrence in the irradiated field, and 13 patients experienced recurrence outside the irradiated field. 29 patients underwent TACE and only 2 patients underwent TAI. The mean number of previous PBT treatments was 1.3 ± 0.6 (range: 1–4). The median interval from the earliest PBT treatment to hepatic angiography was 559 days (range: 34–5,383 days), and the median interval from the latest PBT treatment to hepatic angiography was 464 days (range: 34–5,383 days). Abnormal staining of the irradiated liver parenchyma was observed in 22 patients, which obscured the angiographic tumor staining in 4 patients. Development of a tortuous tumor feeder vessel was observed in 13 patients. Development of an extrahepatic collateral pathway was observed in 7 patients. Development of an arterioportal or arteriovenous shunt was observed in 4 patients. Based on these findings, we conclude that PBT was associated with various angiographic findings during subsequent transarterial chemotherapy for recurrent HCC, and familiarity with these findings will be important in developing appropriate treatment plans.


2015 ◽  
Vol 21 (4) ◽  
pp. 454-467 ◽  
Author(s):  
Kellie Young ◽  
Nicholas Fidelman ◽  
Francis Y. Yao ◽  
Nancy K. Hills ◽  
Maureen P. Kohi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document